- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01011400
Ultrasonic Measurements of the Clitoris in Fetuses
August 27, 2013 updated by: Meir Medical Center
Measurements of the Fetal Clitoris by 2D Ultrasound
Abnormal enlargement of the clitoris in fetal life may be a sign for different pathologies.
To the investigators knowledge there is no published nomogram of the clitoris size through gestation and it's assessment is usually subjective.
The purpose of this study is to create a nomogram of clitorial size through gestation by measuring its size in fetuses of different age in the second and third trimester.
Study Overview
Status
Withdrawn
Conditions
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kfar Saba, Israel
- Meir Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 months to 8 months (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
pregnant women with a female fetus in the second or 3 ed trimester
Description
Inclusion Criteria:
- well dated pregnancy
- singleton pregnancy
- female fetus
- appropriate for gestational age
Exclusion Criteria:
- small for gestational age
- other fetal anomalies
- maternal conditions that can cause exposure of the fetus to high androgen environment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (Anticipated)
December 1, 2011
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
November 10, 2009
First Submitted That Met QC Criteria
November 10, 2009
First Posted (Estimate)
November 11, 2009
Study Record Updates
Last Update Posted (Estimate)
August 28, 2013
Last Update Submitted That Met QC Criteria
August 27, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 121-09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ambiguous Genitalia
-
Hospices Civils de LyonUnknown
-
Centro de Atenção ao Assoalho PélvicoCompletedDissatisfaction Appearance of the External Genitalia
-
ThuasneCompletedLymphedema of GenitaliaFrance
-
Sheng-Li Xue, MDNorthern Jiangsu Province People's Hospital; The Second People's Hospital of... and other collaboratorsRecruitingAcute Leukemia of Ambiguous LineageChina
-
St. Jude Children's Research HospitalAbbVie; Gateway for Cancer Research; Karyopharm Therapeutics IncRecruitingRefractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Leukemia of Ambiguous Lineage in Relapse | Refractory Acute Leukemia of Ambiguous LineageUnited States
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); Fred Hutchinson Cancer CenterTerminatedAcute Myeloid Leukemia | Acute Leukemia of Ambiguous LineageUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Refractory Acute Leukemia of Ambiguous Lineage | Recurrent Acute Leukemia of Ambiguous LineageUnited States
-
Children's Oncology GroupRecruitingRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Refractory Acute Leukemia of Ambiguous Lineage | Recurrent Acute Leukemia of Ambiguous Lineage | Recurrent Acute Myeloid Leukemia... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Acute Leukemias of Ambiguous Lineage | Untreated Adult Acute Lymphoblastic Leukemia | Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic LeukemiaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Myeloid NeoplasmUnited States